Form 4 Filing for Damora Therapeutics, Inc.

This filing details transactions by Winslow Garrett, General Counsel of Damora Therapeutics, Inc. On July 3, 2026, Garrett acquired 680 shares of common stock through the settlement of Restricted Stock Units (RSUs) with a reported value of $0, leaving him with 2534 shares. This settlement was part of the vesting of RSUs granted on January 3, 2024, with subsequent vesting occurring every six months. Additionally, on July 6, 2026, Garrett sold 245 shares of common stock at $29.98 per share to cover tax obligations related to the RSU vesting. This sale was mandated by the company's equity incentive plan and is not considered a discretionary trade. Following this transaction, Garrett holds 2289 shares of common stock. The RSUs themselves represent the right to receive one share of common stock upon settlement.